Glazer Capital LLC’s Zura Bio ZURA Stock Holding History

Glazer Capital LLC’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-999,980	Closed	-$10.2M	–	354
2022 Q4	$10.2M	Buy	999,980 +423,433	+73%	+$4.29M	0.26%	124
2022 Q3	$5.79M	Buy	576,547 +298,728	+108%	+$2.99M	0.11%	227
2022 Q2	$2.76M	Buy	277,819 +194,894	+235%	+$1.94M	0.07%	290
2022 Q1	$822K	Buy	82,925 +29,623	+56%	+$292K	0.02%	330
2021 Q4	$526K	Sell	53,302 -12,406	-19%	-$122K	0.01%	477
2021 Q3	$642K	Buy	+65,708	New	+$645K	0.01%	506

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Glazer Capital LLC's ZURA Position: Q1 2023 in Review

Glazer Capital LLC sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 999,980 shares — an estimated $10.2M sold.

Glazer Capital LLC first reported a position in ZURA in Q3 2021 and held it in 6 quarters. The position peaked at $10.2M in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Glazer Capital LLC reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Glazer Capital LLC sold 999,980 Zura Bio shares in Q1 2023, an estimated $10.2M.
Glazer Capital LLC first reported a position in Zura Bio in Q3 2021 and held it in 6 quarters.
Glazer Capital LLC's Zura Bio position peaked at $10.2M in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Glazer Capital LLC's 13F filing for Q1 2023, filed 15 May 2023.